GNH India firefights industrial poisoning

Dr. Piyush Gupta, Director of GNH India Pharmaceuticals Ltd. says “The rise in the demand for these antidotes has a direct correlation with the substantive increase in industrialization and urbanization. While most states have put a heavy foot on accelerating these development projects; little to nothing is being done with regard to the human cost”.

The shortcomings are two-fold- one lies in the insufficient safety measures at the project site and the other in the lack of proactively stocking medicines that are life-saving in hospitals. About 48,000 workers in India lose their lives due to occupational accidents, of which the construction sector contributes 24.20% of the fatalities, says a recent report based on a study conducted by the British Safety Council last year.

Commenting on this predicament, Dr. Piyush Gupta, Director of GNH India Pharmaceuticals Ltd. said, “The number of orders received by us from all over India reveals the state of shortage of antidotes for industrial poisoning, in our country and our hospitals. Despite having international standards in place by the WHO – ILO in addition to a policy, a system, and a program on occupational safety and health, occupational hazards have been a neglected area in our country. Various hindrances like administrative difficulties, lack of infrastructure, and  paucity and ineffectiveness of the guidelines pose a challenge in making the antidotes available for the patients in need.”

GNH India, with its principal that at least rudimentary medical aid reached those who needed it the most; irrespective of geographical boundaries or political conflict. With its pioneer footing, it has proven to be a succor for the country’s vexatious cases of industrial poisoning with an effort towards drawing attention apropos the rising concern of the insufficient stocking of the antidotes in the hospitals.